AzTrials
AzTrials

AnesthesiaNCT04520919

Feasibility Study of a Hemodynamic Parameter Algorithm

An observational study of Anesthesia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

An algorithm to calculate hemodynamic parameters based on blood pressure waveform was developed by collecting arterial blood pressure of patients during surgery Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Anesthesia
What is being tested?
anesthesia;Radial artery puncture
How many people
139 participants
Where
1 siteChina
Study dates
1 Mar 2020to 30 Jun 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: patients who need surgery

Who may be able to join

  • surgery patients

Who cannot join

  • Weight ≤18kg arrhythmology cardiac disfunction

Trial locations and contacts

1 site in 1 country.

QIWEN YU, undergraduate contact

+8618668022199

yuqw@zju.edu.cn

China1 site, 1 recruiting
  • The Second Affiliated Hospital of Zhejiang University anesthesiology department

    Hangzhou, Zhejiang, 310000

    Min Yan, Doctor, zryanmin@zju.edu.cn

    Recruiting

Other trials in China

About this study

An algorithm to calculate hemodynamic parameters based on blood pressure waveform was developed by collecting arterial blood pressure of patients during surgery

Conditions
Anesthesia
Being tested
anesthesia;Radial artery puncture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • anesthesia;Radial artery punctureOther

    we chose the patients who need to monitor invasive blood pressure to obtain high-fidelity arterial waveforms

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. arterial blood pressure

    a high-fidelity blood pressure waveforms

    Measured: 30min~1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2020
  2. Study start1 Mar 2020
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion30 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
139 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04520919
Sponsor's protocol ID
2019-001
Status last verified
Jan 2020
First submitted
18 Aug 2020
Last updated
20 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact QIWEN YU, undergraduate (+8618668022199, yuqw@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

arterial blood pressure (time frame: 30min~1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Feasibility Study of a Hemodynamic Parameter Algorithm | AzTrials